Interobserver variability in endometrial intraepithelial neoplasia
Abstract
Introduction: Endometrial hyperplasia is a common disease and precursor of endometrial carcinoma. WHO hyperplasia classification system which is unreliable has confusing and overlapping criteria which prompted the development of a system based on Endometrial Intraepithelial Neoplasia (EIN).
Objectives: (1) To review Endometrial Intraepithelial Neoplasia. (2) To reclassify WHO classification of endometrial hyperplasia into EIN and non-EIN category and to study the interobserver variability.
Materials and Methods: In 102 patients diagnosed as WHO hyperplasia reclassification was done by 2 separate pathologists using EIN criteria 1) Glandular crowding. 2) Cytologic demarcation. 3) Size of the lesion should exceed 1mm. 4) Exclude benign processes 5) Exclude carcinoma. Inter observer variability was studied.
Results: Out of 102 cases, 53 (51.96%) cases were earlier diagnosed as simple typical hyperplasia, 12 (11.76%) cases as complex typical hyperplasia, 21 (20.58%) cases as simple atypical hyperplasia and 16 (15.68%) cases as complex atypical hyperplasia. 26% were re-classified as EIN and 64% as non-EIN lesions by first pathologist. Second pathologist reclassified 28% as EIN and 62% as non-EIN lesions. Interobserver variability existed in only 2 cases of complex hyperplasia with atypia reclassified by second pathologist.
Conclusion: EIN criteria has less interobserver variability than WHO classified hyperplasia system and can be easily applied to routine haematoxylin and eosin sections. EIN diagnosis prevents the progression to endometrial adenocarcinoma and helps in clinical management which is less intensive than for adenocarcinoma.
Downloads
References
2. Mirza T, Akram S, Mirza A, Aziz S, Mirza T, Mustansa T. Histopathological Pattern of Abnormal Uterine Bleeding in Endometrial Biopsies. J Basic App Sci. 2012;8(1):114-117.
3. Baral R, Pudasaini S. Histopathological pattern of endometrial samples in abnormal uterine bleeding. J Pathol Nepal. 2011;1(1):13-16. doi: https://doi.org/10.3126/jpn.v1i1.4443.
4. Dangal G. A study of endometrium of patients with abnormal uterine bleeding at Chitwan valley. Kathmandu Univ Med J. 2003;1(2):110-112.
5. Baak JP, Orbo A, van Diest PJ, Jiwa M, de Bruin P, Broeckaert M, et al. Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias. Am J Surg Pathol 2001;25(7):930-935.
6. Kurman R, Norris H: Endometrial hyperplasia and metaplasia in Blaustein’s Pathology of the Female Genital Tract. Springer-Verlag. 1987;322-337.
7. Mutter GL Endometrial intraepithelial neoplasia (EIN). Will it bring order to chaos? The Endometrial Collaborative Group. Gynecol Oncol 2000;76(3):287-290. doi: https://doi.org/10.1006/gyno.1999.5580.
8 Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ: Uterine corpus Histological typing of Female Genital Tract Tumors. New York, Springer-Verlag; 1994; 13-31.
9. Kenneth M, Feeley Michael Wells: Advances in Endometrial Pathology. Recent advances in Histopathology- 19;20-21.
10. Mutter GL: EIN Central [On Line]; http:/www.endometrium.org, 2001.
11. Usubutun A, Mutter GL, Saglam A, Dolgun A, Ozkan EA, Ince T et al. Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists. Mod Pathol. 2012;25(6):877-884. doi: 10.1038/modpathol.2011.220.
12. Hecht JL, Ince TA, Baak JP, Baker HE, Ogden MW, Mutter GL. Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis. Mod Pathol 2005;18(3):324-333.
14. Lacey JV Jr, Mutter GL, Nucci MR, Ronnett BM, Ioffe OB, Rush BB et al. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies. Cancer. 2008;113(8):2073-2081. doi: 10.1002/cncr.23808.
15. Sobczuk A, Wrona M, Pertyński T. [New views on hyperplastic endometrial lesions classification— endometrial intraepithelial neoplasia (EIN)].Ginekol Pol 2007;78(12):986-989.
16. Elke A. Jarboe, George L. Mutter.2010. Endometrial intraepithelial neoplasia. Seminars in Diagnostic Pathol. 2010;27(4):215-225.
17. Kane SE, Hecht JL. Endometrial intraepithelial neoplasia terminology in practice: 4-year experience at a single institution. Int J Gynecol Pathol. 2012;31(2):160-165. doi: 10.1097/PGP.0b013e318227505a.
18. Khanna R, Rupala G, Khanna V. Endometrial Intraepithelial Neoplasia and Its Correlation with WHO Classified Endometrial Hyperplasia. Int J Pathol. 2011;12(1).
19. Mutter GL, Ince TA, Baak JP, Kust GA, Zhou XP, Eng C. Molecular identification of latent precancers in histologically normal endometrium. Cancer Res. 2001;61(11):4311-4314.
20. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer. 1985;56(2):403-412.
21. Baak JP, Mutter GL, Robboy S, van Diest PJ, Uyterlinde AM, Orbo A, et al. The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer. 2005;103(11):2304-2312. doi: https://doi.org/10.1002/cncr.21058.
22. Zaino R, Trimble C, Silverberg S, et al. Reproducibility of the diagnosis of atypical endometrial hyperplasia (AEH); a gynecologic oncology group (GOG) study. Lab invest 2004;84(1):218A.
23. Kendall BS, Ronnett BM, Isacson C, et al. Reproducibility of diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol 1998;22(8):1012-1019.
24. Quade BJ, Robboy SJ. Uterine smooth muscle tumours. In : Robboy SJ, Mutter GL, Prat J, Bentley RC, Russell P, Anderson MC, editors. Robboy’s pathology of female reproductive tract. (2nd edition). China: Churchill Livingstone Elsevier. 2011:457-484.
OAI - Open Archives Initiative
